News

A study by a FaBiT research group shows how a modification of the NDRG1 protein regulates its localization and interactions with Ni and cell membranes, opening the way to new therapeutic strategies.

On 10 March, meet companies and test your approach to the job market. Sign up now!

The Professor of Pharmaceutical Chemistry of the Department of Pharmacy and Biotechnology has been appointed Editor-in-Chief of one of the most authoritative journals in the field.

Presentation of the degree programmes of the Department of Pharmacy and Biotechnology

Submit your candidacy from 9 March and vote online on 15 and 16 April 2026 to elect representatives to the Degree Programme Councils and the Department Board.

Identifying biomarkers to enable early detection of the disease and improve the quality of life of millions of women is at the heart of UNSEEN, the project led by a FaBiT research group.

The FaBiT study will explore the biological variables underlying the different prevalence between men and women, with the aim of developing personalized diagnostic and therapeutic strategies.

Discover what’s new, explore the contents and objectives in depth, assess the opportunities, and choose the path that best aligns with your interests and professional goals.

On 10 February, take part in the event where public bodies and companies meet PhD holders to present job opportunities that match the skills they have acquired.